Clinical Trial Update: Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of calcitriol, mitoxantrone, and prednisone in patients with metastatic prostate cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• Mitoxantrone (mitoxantrone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED